Evidence map›Paper›PMID 25390655›Full record

SynthesisPloS one2014

Leucocyte telomere length and risk of type 2 diabetes mellitus: new prospective cohort study and literature-based meta-analysis.

Peter Willeit, Julia Raschenberger, Emma E Heydon, Sotirios Tsimikas, Margot Haun, Agnes Mayr, Siegfried Weger, Joseph L Witztum, Adam S Butterworth, Johann Willeit and 2 more

Abstract readMeta-Analysis
In one paragraph

Synthesis in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 109 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
109citing papers in PubMed, 8 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

109 citing papers in PubMed, 8 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. The relationship between telomere length and mortality risk in non-model vertebrate systems: a meta-analysis.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2018
    Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Association of nutraceutical supplements with longer telomere length.International journal of molecular medicine · 2019
    Trial
  12. Trial
  13. Trial
  14. Article
  15. Review
  16. Article
  17. Type 2 Diabetes From the Perspective of Telomere Biology.Endocrinology, diabetes & metabolism · 2026
    Review
  18. Telomeric autophagy in human health, aging, and diseases.Frontiers in molecular biosciences · 2026
    Review
  19. Article
  20. Review

49 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Peter WilleitDepartment of Neurology, Innsbruck Medical University, Innsbruck, Austria; Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Julia RaschenbergerDivision of Genetic Epidemiology, Innsbruck Medical University, Innsbruck, Austria.
Emma E HeydonDepartment of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Sotirios TsimikasDepartment of Medicine, University of California San Diego, La Jolla, United States of America.
Margot HaunDivision of Genetic Epidemiology, Innsbruck Medical University, Innsbruck, Austria.
Agnes MayrDepartment of Laboratory Medicine, Bruneck Hospital, Bruneck, Italy.
Siegfried WegerDepartment of Internal Medicine, Bruneck Hospital, Bruneck, Italy.
Joseph L WitztumDepartment of Medicine, University of California San Diego, La Jolla, United States of America.
Adam S ButterworthDepartment of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Johann WilleitDepartment of Neurology, Innsbruck Medical University, Innsbruck, Austria.
Florian KronenbergDivision of Genetic Epidemiology, Innsbruck Medical University, Innsbruck, Austria.
Stefan KiechlDepartment of Neurology, Innsbruck Medical University, Innsbruck, Austria.

Funding

British Heart Foundation RG/08/014/24067Medical Research Council MR/L003120/1
6 · The paper itself

Abstract

backgroundShort telomeres have been linked to various age-related diseases. We aimed to assess the association of telomere length with incident type 2 diabetes mellitus (T2DM) in prospective cohort studies.

methodsLeucocyte relative telomere length (RTL) was measured using quantitative polymerase chain reaction in 684 participants of the prospective population-based Bruneck Study (1995 baseline), with repeat RTL measurements performed in 2005 (n = 558) and 2010 (n = 479). Hazard ratios for T2DM were calculated across quartiles of baseline RTL using Cox regression models adjusted for age, sex, body-mass index, smoking, socio-economic status, physical activity, alcohol consumption, high-density lipoprotein cholesterol, log high-sensitivity C-reactive protein, and waist-hip ratio. Separate analyses corrected hazard ratios for within-person variability using multivariate regression calibration of repeated measurements. To contextualise findings, we systematically sought PubMed, Web of Science and EMBASE for relevant articles and pooled results using random-effects meta-analysis.

resultsOver 15 years of follow-up, 44 out of 606 participants free of diabetes at baseline developed incident T2DM. The adjusted hazard ratio for T2DM comparing the bottom vs. the top quartile of baseline RTL (i.e. shortest vs. longest) was 2.00 (95% confidence interval: 0.90 to 4.49; P = 0.091), and 2.31 comparing the bottom quartile vs. the remainder (1.21 to 4.41; P = 0.011). The corresponding hazard ratios corrected for within-person RTL variability were 3.22 (1.27 to 8.14; P = 0.014) and 2.86 (1.45 to 5.65; P = 0.003). In a random-effects meta-analysis of three prospective cohort studies involving 6,991 participants and 2,011 incident T2DM events, the pooled relative risk was 1.31 (1.07 to 1.60; P = 0.010; I2 = 69%). CONCLUSIONS/

interpretationLow RTL is independently associated with the risk of incident T2DM. To avoid regression dilution biases in observed associations of RTL with disease risk, future studies should implement methods correcting for within-person variability in RTL. The causal role of short telomeres in T2DM development remains to be determined.

Indexed as

Telomere ShorteningAdultAgedAge FactorsAlcohol DrinkingBody Mass IndexCholesterol, HDLC-Reactive ProteinDiabetes Mellitus, Type 2FemaleHumansLeukocytesMaleMiddle AgedMotor ActivityProportional Hazards ModelsCholesterol, HDLC-Reactive Protein

Identifiers

PMID25390655
PMCPMC4229188

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.